4105-38-8
Chemical Structure
Uridine triacetate
Synonym(s): Tri-O-acetyl uridine
- CAS No.: 4105-38-8
- Formula:C15H18N2O9
- Molecular Weight:370.31
IUPAC Name: (2R,3R,4R,5R)-2-(acetoxymethyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate
InChIKey: AUFUWRKPQLGTGF-FMKGYKFTSA-N
SMILES: O=C1NC(C=CN1[C@H]2[C@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O2)=O
Biological Activity: Uridine triacetate (Tri-O-acetyl uridine) is an orally active proagent of Uridine (HY-B1449). Uridine triacetate is quickly absorbed in the gut, and is rapidly deacetylated in the circulation to yield free uridine. Uridine triacetate is used for the research of 5-fluorouracil (5-FU) and capecitabine toxicity, or early-onset cardiac or central nervous system (CNS)[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Uridine triacetate | 99.88% | Uridine triacetate (Tri-O-acetyl uridine) is an orally active proagent of Uridine (HY-B1449). Uridine triacetate is quickly absorbed in the gut, and is rapidly deacetylated in the circulation to yield free uridine. Uridine triacetate is used for the research of 5-fluorouracil (5-FU) and capecitabine toxicity, or early-onset cardiac or central nervous system (CNS). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
[U-13C,15N]-hTau-441 | [U-13C,15N]-hTau-441 is the 13C- and 15N-labeled hTau-441. Abnormal levels and aggregation of hTau-441 in the brain are considered key factors in the pathogenesis of Alzheimer's disease (AD). This isotope can be used in NMR studies of disease mechanisms and in mass spectrometry analysis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
[U-15N]-hTau-441 | [U-15N]-hTau-441 is the 15N-labeled hTau-441. Abnormal levels and aggregation of hTau-441 in the brain are considered key factors in the pathogenesis of Alzheimer's disease (AD). This isotope can be used in NMR studies of disease mechanisms and in mass spectrometry analysis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
